![Suresh Nair, MD, looks forward to the future of health care with Jefferson Health and LVHN working as one](/sites/default/files/styles/400_wide/public/2024-08/N29726_Suresh%20Nair%20Testimonial-Blog.jpg?itok=ClpGgZ3w&cb=45f8835d)
As Physician in Chief at Lehigh Valley Topper Cancer Institute, Suresh Nair, MD, has helped bring life-changing and lifesaving treatments to people facing cancer. In his area of specialization, melanoma care, Dr. Nair led clinical trials at Lehigh Valley Health Network (LVHN) that ultimately resulted in immunologic treatments, such as nivolumab (Opdivo) and ipilimumab (Yervoy), being approved for the treatment of melanoma and many other types of cancer.
Dr. Nair’s passion for cancer care, and particularly for guiding care for people facing melanoma, was fostered through his medical school training at Thomas Jefferson University in Philadelphia. As Jefferson Health and LVHN join together, Dr. Nair recalls his journey into medicine, his training at Jefferson and his optimism for the future of care with these two organizations working in concert.